Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |